These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15541439)

  • 1. Chlorproguanil-dapsone for malaria.
    Standing JF; Wong IC
    Lancet; 2004 Nov 13-19; 364(9447):1752-3; author reply 1753. PubMed ID: 15541439
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorproguanil-dapsone for malaria in Africa.
    Looareesuwan S; Imwong M; Wilairatana P
    Lancet; 2004 Jun; 363(9424):1838-9. PubMed ID: 15183616
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
    Alloueche A; Bailey W; Barton S; Bwika J; Chimpeni P; Falade CO; Fehintola FA; Horton J; Jaffar S; Kanyok T; Kremsner PG; Kublin JG; Lang T; Missinou MA; Mkandala C; Oduola AM; Premji Z; Robertson L; Sowunmi A; Ward SA; Winstanley PA
    Lancet; 2004 Jun; 363(9424):1843-8. PubMed ID: 15183620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
    Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
    Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
    Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
    J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
    Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
    Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of Lapdap, an affordable new treatment for malaria.
    Lang T; Greenwood B
    Lancet Infect Dis; 2003 Mar; 3(3):162-8. PubMed ID: 12614733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
    Fanello CI; Karema C; Avellino P; Bancone G; Uwimana A; Lee SJ; d'Alessandro U; Modiano D
    PLoS One; 2008; 3(12):e4031. PubMed ID: 19112496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
    Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
    Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
    Simpson JA; Hughes D; Manyando C; Bojang K; Aarons L; Winstanley P; Edwards G; Watkins WA; Ward S
    Br J Clin Pharmacol; 2006 Mar; 61(3):289-300. PubMed ID: 16487222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug company to offer new malaria drug cheaply in Africa.
    Pincock S
    BMJ; 2003 Aug; 327(7411):360. PubMed ID: 12919982
    [No Abstract]   [Full Text] [Related]  

  • 12. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and identification of a degradant in chlorproguanil-dapsone-artesunate (Dacart™) tablets.
    Bardsley B; Barry SJ; Drozdz MA; Hancock SA; Okafo GN; Szafran MM
    J Pharm Biomed Anal; 2011 Feb; 54(3):610-3. PubMed ID: 20970278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
    Winstanley P; Watkins W; Muhia D; Szwandt S; Amukoye E; Marsh K
    Trans R Soc Trop Med Hyg; 1997; 91(3):322-7. PubMed ID: 9231209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
    Edstein MD; Yeo AE; Shanks GD; Rieckmann KH
    Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
    Winstanley P
    Trop Med Int Health; 2001 Nov; 6(11):952-4. PubMed ID: 11703851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
    Tiono AB; Dicko A; Ndububa DA; Agbenyega T; Pitmang S; Awobusuyi J; Pamba A; Duparc S; Goh LE; Harrell E; Carter N; Ward SA; Greenwood B; Winstanley PA
    Am J Trop Med Hyg; 2009 Dec; 81(6):969-78. PubMed ID: 19996424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics.
    Luzzatto L
    Lancet; 2010 Aug; 376(9742):739-41. PubMed ID: 20599264
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in Kenya.
    Nevill CG; Lury JD; Mosobo MK; Watkins HM; Watkins WM
    Trans R Soc Trop Med Hyg; 1994; 88(3):319-20. PubMed ID: 7974677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.